<DOC>
	<DOCNO>NCT02746666</DOCNO>
	<brief_summary>The purpose study investigate impact pharmacist behavioral intervention 's influence breast cancer patient ' quality life . Croatian randomize controlled trial . Targeted population : general population breast cancer patient first adjuvant anthracycline chemotherapy . Primary outcome : difference EORTC QLQ-BR23 questionnaire result baseline 3 week cycle .</brief_summary>
	<brief_title>Pharmacist 's Influence Breast Cancer Patient Quality Life</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Early breast cancer First adjuvant chemotherapy Chemotherapy protocol : anthracycline x 4 Cardiovascular comorbidities Regular nausea vomit six month enrollment Unable answer quality life questionnaire</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>